Literature DB >> 16430231

Two forms of human cytoplasmic arginyl-tRNA synthetase produced from two translation initiations by a single mRNA.

Yong-Gang Zheng1, Hui Wei, Chen Ling, Min-Gang Xu, En-Duo Wang.   

Abstract

Human cytoplasmic arginyl-tRNA synthetase (ArgRS) is a component of a macromolecular complex consisting of at least nine tRNA synthetases and three auxiliary proteins. In mammalian cells, ArgRS is present as a free protein as well as a component of the complex. Via an alignment of ArgRSs from different vertebrates, the genes encoding full-length human cytoplasmic ArgRS and an N-terminal 72-amino acid deletion mutant (hcArgRS and DeltaNhcArgRS, respectively) were subcloned and expressed in Escherichia coli. The two ArgRS products were expressed as a soluble protein in E. coli. The level of production of DeltaNhcArgRS in E. coli and its specific activity were higher than those for hcArgRS. By Western blot analysis, using an antibody against the purified DeltaNhcArgRS, the two forms of ArgRS were detected in three human cell types. The 5'-end cDNA sequence, as confirmed by 5'RACE (5'-rapid amplification of cDNA ends), contained three start codons. Through mutation of the three codons, the two human cytoplasmic ArgRSs were found to be produced in different amounts, indicating that they resulted from two different translation initiation events. Here we show evidence that two forms of human cytoplasmic ArgRS were produced from two translational initiations by a single mRNA.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16430231     DOI: 10.1021/bi051675n

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  21 in total

1.  Hemin binds to human cytoplasmic arginyl-tRNA synthetase and inhibits its catalytic activity.

Authors:  Fang Yang; Xian Xia; Hui-Yan Lei; En-Duo Wang
Journal:  J Biol Chem       Date:  2010-10-05       Impact factor: 5.157

2.  An important role for the multienzyme aminoacyl-tRNA synthetase complex in mammalian translation and cell growth.

Authors:  Sophia V Kyriacou; Murray P Deutscher
Journal:  Mol Cell       Date:  2008-02-29       Impact factor: 17.970

3.  Caenorhabditis elegans evolves a new architecture for the multi-aminoacyl-tRNA synthetase complex.

Authors:  Svitlana Havrylenko; Renaud Legouis; Boris Negrutskii; Marc Mirande
Journal:  J Biol Chem       Date:  2011-06-17       Impact factor: 5.157

4.  Mutations in RARS cause a hypomyelination disorder akin to Pelizaeus-Merzbacher disease.

Authors:  Michael Nafisinia; Nara Sobreira; Lisa Riley; Wendy Gold; Birgit Uhlenberg; Claudia Weiß; Corinne Boehm; Kristina Prelog; Robert Ouvrier; John Christodoulou
Journal:  Eur J Hum Genet       Date:  2017-07-26       Impact factor: 4.246

Review 5.  Architecture and metamorphosis.

Authors:  Min Guo; Xiang-Lei Yang
Journal:  Top Curr Chem       Date:  2014

Review 6.  Functional expansion of human tRNA synthetases achieved by structural inventions.

Authors:  Min Guo; Paul Schimmel; Xiang-Lei Yang
Journal:  FEBS Lett       Date:  2010-01-21       Impact factor: 4.124

7.  The mRNA of human cytoplasmic arginyl-tRNA synthetase recruits prokaryotic ribosomes independently.

Authors:  Fang Yang; Quan-Quan Ji; Liang-Liang Ruan; Qing Ye; En-Duo Wang
Journal:  J Biol Chem       Date:  2014-07-25       Impact factor: 5.157

Review 8.  tRNA synthetase: tRNA aminoacylation and beyond.

Authors:  Yan Ling Joy Pang; Kiranmai Poruri; Susan A Martinis
Journal:  Wiley Interdiscip Rev RNA       Date:  2014-04-04       Impact factor: 9.957

9.  Distinct pathogenic mechanisms of various RARS1 mutations in Pelizaeus-Merzbacher-like disease.

Authors:  Guang Li; Gilbert Eriani; En-Duo Wang; Xiao-Long Zhou
Journal:  Sci China Life Sci       Date:  2021-01-28       Impact factor: 6.038

10.  Translational fidelity maintenance preventing Ser mis-incorporation at Thr codon in protein from eukaryote.

Authors:  Xiao-Long Zhou; Zhi-Rong Ruan; Qian Huang; Min Tan; En-Duo Wang
Journal:  Nucleic Acids Res       Date:  2012-10-23       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.